APAC vaccine distribution hub to be established in SG

It will provide easier access to vaccines.

Zuellig Pharma declared that it entered into a deal with global biopharma company, GSK, to help set up its first vaccine distribution hub in the region.

The vaccine distribution hub will serve 13 Asian countries and will adopt a sea transport model to cut its supply chain carbon footprint. This will allow reduced transportation carbon emissions by at least 30%, compared to air transport.

Under the agreement, Zuellig Pharma Singapore will provide GSK with warehousing and distribution services in cold-chain management for its vaccines. 

The vaccine hub will also make use of Zuellig Pharma's expertise in blockchain technology for China, one of GSK's largest APAC markets. 

The use of eZTracker, Zuellig Pharma's end-to-end blockchain solution, will improve resiliency of GSK's supply chain to enable greater traceability of its vaccines. It will also enable product visibility to address the proliferation of counterfeit healthcare products in Asia.